F19.26
Other psychoactive substance dependence with psychoactive substance-induced persisting amnestic disorder
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code F19.26 refers to a condition where an individual develops dependence on various psychoactive substances, accompanied by a lasting memory impairment caused by those substances. This disorder is characterized by ongoing reliance on particular drugs and persistent issues with memory that can significantly affect daily life. Recognizing this condition is important for appropriate treatment and management, although it requires a thorough evaluation by healthcare professionals.
Causes & Symptoms
Clinical Causes: Chronic abuse of psychoactive substances such as opioids, benzodiazepines, stimulants, or other mind-altering drugs. Prolonged exposure to high doses or frequent use of specific substances leading to dependence. Genetic predisposition that affects how an individual processes and reacts to certain drugs. Co-occurring mental health conditions that may increase vulnerability to both dependence and cognitive impairments. Environmental factors, including stress and social influences, that contribute to sustained substance use.
Key Symptoms: Persistent memory loss or difficulty recalling past events or information. Craving or compulsive seeking of the psychoactive substance despite negative consequences. Impairment in learning new information or retaining recent experiences. Withdrawal symptoms when not using the substance, which may include anxiety, irritability, or physical discomfort. Impaired cognitive function impacting daily activities and personal relationships. Changes in mood or behavior, including depression or agitation related to substance dependence.
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a comprehensive assessment by a healthcare professional, including clinical interviews, medical history, and possibly neuropsychological testing to evaluate cognitive deficits. Healthcare providers may utilize laboratory tests to confirm substance use and rule out other medical conditions. Diagnosis of F19.26 specifically requires evidence of both psychoactive substance dependence and there to be a persistent amnestic disorder attributable to substance use.
Treatment Protocols: Managing this disorder generally involves a combination of approaches tailored to the individual. Treatment options may include:
Clinical Advice & FAQs
Billing Guidance
Is F19.26 a billable ICD-10 code?
Yes, F19.26 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F19.26?
Clinical documentation must specify the nature of Other psychoactive substance dependence with psychoactive substance-induced persisting amnestic disorder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference